Metrikler
Makaleler
Tümü (2)
SCI-E, SSCI, AHCI (2)
SCI-E, SSCI, AHCI, ESCI (2)
Scopus (1)
2017
20171. Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
Eskazan A. E., Keskin D.
Therapeutic advances in hematology
, cilt.8, ss.237-243, 2017 (SCI-Expanded)
2016
20162. Dasatinib for the treatment of chronic myeloid leukemia: patient selection and special considerations.
Keskin D., Sadri S., Eskazan A. E.
Drug design, development and therapy
, cilt.10, ss.3355-3361, 2016 (SCI-Expanded, Scopus)